Cassava (which some readers might have eaten as tapioca or under the name yuca) is a plant harvested in tropical and subtropical regions. China is already the third-largest ethanol producer in the ...
A research team investigates how genome editing can be harnessed to accelerate cassava breeding and improve key traits.
Cassava Sciences has officially stopped the development of its investigational drug simufilam in Alzheimer’s disease after it failed to show benefit in a second Phase III trial. The company is ...
VIENTIANE, March 25 (Xinhua) -- Laos recorded a trade deficit of 56 million U.S. dollars in January, according to the latest figures from the Lao Trade Portal website.
Cassava Sciences said on Tuesday its Alzheimer's drug simufilam, which has been at the center of regulatory scrutiny, failed in a second late-stage study, sending shares of the company down 20% in ...
These results were unambiguous,” said Rick Barry, President and Chief Executive Officer of Cassava. “Cassava will discontinue all efforts to develop simufilam for Alzheimer’s disease and we ...
Cassava Sciences' pivot to TSC via a Yale license deal for simufilam addresses both new indications and reputation issues but faces significant clinical and market challenges. Preclinical studies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback